ALDX — Aldeyra Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Aldeyra Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	77.9	230	174	143	101
Net Total Receivables	—	—	—	0	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	83.1	233	181	148	104
Net Property, Plant And Equipment	0.293	0.384	0.269	0.517	0.267
Other Long Term Assets
Total Assets	83.4	233	181	148	105
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12.4	11.8	15.4	22.3	18.6
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	23.8	27.4	30.3	28.5	33.6
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	59.5	206	151	120	71
Total Liabilities & Shareholders' Equity	83.4	233	181	148	105
Total Common Shares Outstanding